References
- Mansour S, Brice GW, Jeffery S, Mortimer P. Lymphedema-Distichiasis Syndrome. In: MP Adam, HH Ardinger, RA Pagon, SE Wallace, LJH Bean, et al., editors. GeneReviews(R). 1993. Seattle (WA).
- Yildirim-Toruner C, Subramanian K, El Manjra L, Chen E, Goldstein S, Vitale E. A novel frameshift mutation of FOXC2 gene in a family with hereditary lymphedema-distichiasis syndrome associated with renal disease and diabetes mellitus. Am J Med Genet A 2004; 131(3): 281-86.
- Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000; 67(6): 1382-1388.1107847410.1086/316915
- National Library of Medicine (US). Lymphedema-distichiasis syndrome. Bethesda (MD): The Library; Genetics Home Reference. 2014 (Internet).
- Brice G, Mansour S, Bell R, Collin JR, Child AH, Brady AF, Sarfarazi M, Burnand KG, Jeffery S, Mortimer P, Murday VA. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 2002; 39(7): 478-83.1211447810.1136/jmg.39.7.478
- http://www.genecards.org/cgi-bin/carddisppl?gene=FOXC2&keywords=foxc2#summaries
- Zhang Y, Zhang Y. Forkhead box C2 promotes the invasion ability of human trophoblast cells through Hedgehog (Hh) signaling pathway. Cell Biol Int. 2018; (Epub ahead of print).29465790
- Chen B, Gagnon M, Shahangian S, Anderson NL, Howerton DA, Boone JD; Centers for Disease Control and Prevention (CDC). Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions. MMWR Recomm Rep. 2009; 58(RR-6):1-37; quiz CE-1-4.19521335